haloperidol has been researched along with Alloxan Diabetes in 8 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Haloperidol and GHB produced catalepsy in control and diabetic rats; haloperidol was less potent in diabetic rats (D(50)=0." | 1.33 | Streptozotocin-induced diabetes differentially modifies haloperidol- and gamma-hydroxybutyric acid (GHB)-induced catalepsy. ( France, CP; Koek, W; Sevak, RJ, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rutledge, LP | 1 |
| Ngong, JM | 1 |
| Kuperberg, JM | 1 |
| Samaan, SS | 1 |
| Soliman, KF | 1 |
| Kolta, MG | 1 |
| Luippold, G | 1 |
| Beilharz, M | 1 |
| Wehrmann, M | 1 |
| Unger, L | 1 |
| Gross, G | 1 |
| Mühlbauer, B | 1 |
| Sevak, RJ | 1 |
| Koek, W | 1 |
| France, CP | 1 |
| Levine, AS | 1 |
| Morley, JE | 1 |
| Wilcox, G | 1 |
| Brown, DM | 1 |
| Handwerger, BS | 1 |
| Kamei, J | 1 |
| Saitoh, A | 1 |
| Iwamoto, Y | 1 |
| Funada, M | 1 |
| Suzuki, T | 1 |
| Misawa, M | 1 |
| Nagase, H | 1 |
| Kasuya, Y | 1 |
| Sumiyoshi, T | 1 |
| Ichikawa, J | 1 |
| Meltzer, HY | 1 |
| Mardon, K | 1 |
| Kassiou, M | 1 |
| Donald, A | 1 |
| Ahmad, Q | 1 |
| Merali, Z | 1 |
8 other studies available for haloperidol and Alloxan Diabetes
| Article | Year |
|---|---|
Dopaminergic system modulation of nociceptive response in long-term diabetic rats.
Topics: Animals; Behavior, Animal; Blood Glucose; Brain Chemistry; Bromocriptine; Diabetes Mellitus, Experim | 2002 |
Effect of dopamine D3 receptor blockade on renal function and glomerular size in diabetic rats.
Topics: Animals; Cattle; Diabetes Mellitus, Experimental; Domperidone; Dopamine Antagonists; Glomerular Filt | 2005 |
Streptozotocin-induced diabetes differentially modifies haloperidol- and gamma-hydroxybutyric acid (GHB)-induced catalepsy.
Topics: Animals; Catalepsy; Diabetes Mellitus, Experimental; Dizocilpine Maleate; Dopamine Antagonists; Dose | 2005 |
Tail pinch behavior and analgesia in diabetic mice.
Topics: Animals; Consummatory Behavior; Diabetes Mellitus, Experimental; Dopamine; Dose-Response Relationshi | 1982 |
Effects of diabetes on spontaneous locomotor activity in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Benzylidene Compounds; Brain; Corpus Striatum | 1994 |
The effect of streptozotocin-induced diabetes on dopamine2, serotonin1A and serotonin2A receptors in the rat brain.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Brain; Diabetes Mellitus, Experimental; Dopamine An | 1997 |
Effects of streptozotocin-induced diabetes on neuronal sigma receptors in the rat brain.
Topics: Analgesics, Opioid; Animals; Blood Glucose; Brain; Diabetes Mellitus, Experimental; Glycosuria; Guan | 1999 |
The spontaneously diabetic Wistar-BB rat manifests altered grooming and catalepsy responses: implications of impaired dopamine function.
Topics: Animals; Catalepsy; Diabetes Mellitus, Experimental; Dopamine; Grooming; Haloperidol; Male; Rats; Ra | 1988 |